Axsome Therapeutics Inc (NASDAQ: AXSM) stock closed at $89.27 on 1/13/25 after a major increase of 11.5%. Moreover, trading volume in this advance was exceptionally high at 263% of normal. The stock has risen 2.2% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Axsome Therapeutics has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Axsome Therapeutics has a very low Appreciation Score of 6 but a good Power Rating of 72, and the Negative Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment